Phase II trial of 5-fluorouracil and low-dose cisplatin in patients with squamous cell carcinoma of the esophagus

Surgery Today

Volumn 29, Issue 2, 1999, Pages 97-101

  Sekiguchi, Hiroyuki ^a   Akiyama, Seiji ^a   Fujiwara, Michitaka ^a   Nakamura, Hajime ^a   Kondo, Ken ^a   Kasai, Yasushi ^a   Ito, Katsuki ^a   Sakamoto, Junichi ^b   Takagi, Hiroshi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Biochemical modulation; Esophageal carcinoma; Preoperative chemotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; ESOPHAGUS CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA;

EID: 0033061496     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02482231     Document Type: Article

References (32)

1. 1. Earlam R, Cunha-Meio JR (1980) Oesophageal squamous cell carcinoma: a critical review of surgery. Br J Surg 67:381-390
2. 2. Mansour KA, Downey RS (1989) Esophageal carcinoma: surgery without preoperative adjuvant chemotherapy. Ann Thorac Surg 48:201-205
3. 3. Katlic MR, Wilkins EW Jr, Grillo HC (1990) Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 99:929-938
4. 4. Matsubara T, Ueda M, Yanagida O, Nakajima T, Nishi M (1994) How extensive should lymph node dissection be for cancer of the thoracic esophagus? J Thorac Cardiovasc Surg 107:1073-1078
5. 5. Baba M, Aikoh T, Yoshinaka H, Natsugoe S, Fukumoto T, Shimazu H, Akazawa K (1994) Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 219:310-316
6. 6. Sharma S, Fujita H, Yamana H, Kakegawa T (1994) Patterns of lymph node metastasis in 3-field dissection for carcinoma in the thoracic esophagus. Surg Today 24:330-333
7. 7. Nishimaki T, Suzuki T, Tanaka Y, Nakagawa S, Aizawa K, Hatakeyama K (1997) Evaluating the rational extent of dissection in radical esophagectomy for invasive carcinoma of the thoracic esophagus. Surg Today 27:3-8
8. 8. Domitsu K, Akiyama S, Ito K, Kiriyama K, Kodera Y, Kondo K, Watanabe T, Takagi H (1994) Experimental study on chemotherapy using adsorbent charcoal with CDDP administered directly into the mediastinum following esophagectomy. Surg Today 24:1068-1072
9. 9. Poplin EA, Khanuja PS, Kraut MJ, Herskovic AM, Lattin PB, Cummings G, Gaspar LE, Kinzie JL, Steiger Z, Vaitkevicius VK (1994) Chemoradiotherapy of esophageal carcinoma. Cancer 74:1217-1224
10. 10. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE (1996) Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 14:156-163
11. 11. Hou BS, Xiong QB, Li DJ (1989) Thermo-chemo-radiotherapy of esophageal cancer. Cancer 64:1777-1782
12. 12. Ilson DH, Sirott M, Saltz L, Heelan R, Huang Y, Keresztes R, Kelsen DP (1995) A phase II trial of interferon alpha-2a, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Cancer 75:2197-2202
13. 13. Imamura M, Shimada Y, Kanda Y, Fukumoto M, Yanagibashi K, Miyahara T, Tobe T (1992) Usefulness of preoperative low dose cisplatin treatment for advanced esophageal cancer. Surg Today 22:409-415
14. 14. Kies MS, Rosen ST, Tsang TK, Shetty R, Schneider PA, Wallemark CB, Shields TW (1987) Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 60:2156-2160
15. 15. Hilgenberg AD, Carey RW, Wilkins EW Jr, Choi NC, Mathisen DJ, Grillo HC (1988) Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 45:357-363
16. 16. Ajani JA, Ryan B, Rich TA, McMurtrey M, Roth JA, DeCaro L, Levin B, Mountain C (1992) Prolonged chemotherapy for localised squamous carcinom of the oesophagus. Eur J Cancer 28A:880-884
17. 17. Carey RW, Hilgenberg AD, Wilkins EW Jr, Choi NC, Mathisen DJ, Grillo HC, Wain JC, Logan DL, Bromberg C (1993) Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus. Cancer Invest 11:99-105
18. 18. Coonley CJ, Bains M, Hilaris B, Chapman R, Kelsen DP (1984) Cisplatin and bleomycin in the treatment of esophageal carcinoma: a final report. Cancer 54:2351-2355
19. 19. Shirasaka T, Shimamoto Y, Ohshimo H, Saito H, Fukushima M (1993) Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 32:167-172
20. 20. World Health Organization (1979) WHO handbook for reporting results of cancer treatment. World Health Organization, Geneva
21. 21. Akiyama S, Kodera Y, Sekiguchi H, Fujiwara M, Sakamoto J, Kondo K, Ito K, Endo T, Takagi H (1995) Preoperative intraaortic ultrasonography to determine resectability in advanced oesophageal cancer. Br J Surg 82:1671-1674
22. 22. Hermanek P, Sobin LH (eds) (1987) UICC International Union Against Cancer, TNM classification of malignant tumors, 4th edn. Springer, Berlin Heidelberg New York
23. 23. Japanese Society for Esophageal Disease (1992) Guidelines for clinical and pathologic studies on carcinoma of the esophagus, 8th edn. Kanehara, Tokyo
24. 24. Rosenberg J, Lichter A, Leichman L (1989) Cancer of the esophagus. In: De Vita V, Hellman S, Rosenberg S (eds) Cancer: principles and practice of oncology. Lippincott, Philadelphia, pp 725-764
25. 25. Kelsen D, Hilaris B, Coonley C, Chapman R, Lesser M, Dukeman M, Heelan R, Bains M (1983) Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Am J Med 75:645-652
26. 26. Austin JC, Postier RG, Elkins RC (1986) Treatment of esophageal cancer: the continued need for surgical resection. Am J Surg 152:592-596
27. 27. MacFarlane SD, Hill LD, Jolly PC, Kozarek RA, Anderson RP (1988) Improved results of surgical treatment for esophageal and gastroesophageal junction carcinomas after preoperative combined chemotherapy and radiation. J Thorac Cardiovasc Surg 95:415-422
28. 28. Orringer MB, Forastiere AA, Perez-Tamato C, Urba S, Takasugi BJ, Bromberg J (1990) Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma. Ann Thorac Surg 49:348-355
29. 29. Wolfe WG, Burton GV, Seigler HF, Crocker IR, Vaughn AL (1987) Early results with combined modality therapy for carcinoma of the esophagus. Ann Surg 205:563-571
30. 30. Gill PG, Denham JW, Jamieson GG, Devitt PG, Yeoh E, Olweny C (1992) Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery. J Clin Oncol 10:1037-1043
31. 31. Urba SG, Turrisi AT (1995) Split-course accelerated radiation therapy combined with carboplatin and 5-fluorouracil for palliation of metastatic or unresectable carcinoma of the esophagus. Cancer 75:435-439
32. 32. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326:1593-1598